Pathogenic Microbiology

Slides:



Advertisements
Similar presentations
OVERVIEW OF INDUSTRIAL HYGIENE UNIVERSITY OF HOUSTON – DOWNTOWN CAMPUS.
Advertisements

Common Communicable Diseases
Biosafety in Microbiologic and Biomedical Laboratories The University of Texas at Tyler IACUC Education and Training *Note: Content not specific to UT.
Biosafety in Research Laboratories
Janet Peterson Elements of Biosafety Janet Peterson
Laboratory Biosafety Levels
Laboratory Biosafety Pathogenic Microbiology and Virology Laboratories.
Biosafety in Microbiology laboratory
Laboratory Acquired Infections
Bloodborne Pathogens. What are Bloodborne Pathogens? Bloodborne Pathogens Bacteria Virus.
BIOLOGICAL HAZARDS RISK ASSESSMENT
What Are Communicable Diseases?
WILDLIFE DISEASES: An Overview Gary Witmer and Robert McLean USDA APHIS Wildlife Services National Wildlife Research Center Fort Collins, Colorado.
Perinatal Hepatitis B Prevention
Q Fever By: Mandana Ershadi-Hurt. Q fever is a zoonotic disease caused by Coxiella burnetii, a species of bacteria that is distributed globally. Q fever.
Breakout Group: Best Methods for Studying Contact Transmission November 4, 2010 and November 5, 2010 – Atlanta, GA “Understanding the Modes of Influenza.
Risk Group and Biosafety Level. Classification of Infective Agents by Risk Group Pathogenicity Pathogenicity Infectious Dose Infectious Dose Mode of Transmission.
Staff Health Care Infectious Disease view Jameel Adnan, MD. Community & Primary Health Care KAAU- RABEG BRANCH.
Introduction to Tickborne Diseases
Personal Protective Equipment Biosafety and Biosecurity Awareness Training For Afghan and Pakistani Bioscientists January 12-14, 2010 SAND No P.
Bioterrorism MLAB 2434: Microiology Keri Brophy-Martinez.
How long? How long must a tick remain attached to the skin for at least one day before the bacteria can be transmitted.
The Epidemiology of Bacterial Infections. 2 Epidemiology ‘The study of factors affecting the health and illness of populations’ The study of: - the occurrence.
Nosocomial infection Hospital Infection. Hospital acquired infections Nosocomial infections are those that originate or occur in a hospital or hospital-like.
1 Tularemia This is an infectious disease caused by the organism Francisella tularensis. The disease this organism causes has a large range of hosts, methods.
Bloodborne Pathogens.  Peek  Copy  Save  The OSHA Bloodborne Standard requires training for appropriate employees every:  5 years  12 months.
Chapter 3: Infection Control Outline Disease Transmission and Occupational Exposure Infection Control Agencies and Regulations Infection Control Techniques.
Bronchitis Causes Bronchitis occurs most often during the cold and flu season, usually coupled with an upper respiratory infection. A number of bacteria.
Introduction to Biohazards: Risk Management
Discuss the major characteristics of the four Biosafety Levels. Define “Risk Group” and give an example of each. Discuss how Risk Groups are used in conjunction.
Q Fever By Karissa montano.
Mr. Ramos The Immune System. Introduction to the Human Immune System The immune system protects the body from disease. White Blood Cells (WBC), or leukocytes,
Biosafety Levels Precautions so people researching or trying to identify organisms do not become infected While handling or testing clinical specimens,
Laboratory Acquired Infections (LAIs) Physical Security Personnel Security Material Control & Accountability Transport Security Information Security International.
BLOOD BORNE PATHOGEN TRAINING FOR SCHOOL STAFF WILKES COUNTY SCHOOLS 613 CHERRY STREET N. WILKESBORO, NC
Foot and Mouth Disease Etiology Also, AFTOSA
52 Table 1. Summary of Recommended Biosafety Levels for Infectious Agents. Biosafety Level Agents Practices Safety Equipment (Primary Barriers) Facilities.
DR. MOHAMMED ARIF. ASSOCIATE PROFESSOR AND CONSULTANT VIROLOGIST. Non-arboviruses associated with zoonotic diseases.
By LABORATORY SAFETY MEASURES Dr. Emad AbdElhameed Morad Lecturer of Medical Microbiology and Immunology.
Comparing Microbes Microbes and Infectious Disease The who, what, when, and how of microbes and infectious disease.
Q-fever Coxiella Burnetii Dr. Hani Masaadeh MD PhD.
Blood borne Pathogens. Background  Occupational Safety and Health Administration (OSHA)  Blood borne pathogen standard developed December 6, 1991 
BIOSAFETY LEVEL 2 AWARENESS TRAINING UW Stout Laboratory Safety Biological Safety.
Presented by Lagos Brewery Medical Team. What is common cold ? Common cold is a viral infectious disease of the upper respiratory tract which primarily.
Objectives  Define risk assessment as it relates to biosafety  Understand the risk assessment process and how to implement it  Discuss risk factors.
$1 Million $500,000 $100,000 $50,000 $25,000 $10,000 $5,000 $1,000.
Biological Agents, Biosafety cabinets and Beyond Biological Agents, Biosafety cabinets and Beyond Microbiology laboratory 2005.
RCSD Bloodborne Pathogen Protection Program Presented by Suzanne Wheatcraft, MS, CPG Director of School Environmental Health & Safety.
Chapter 41 The Child with an Infectious Disease Elsevier items and derived items © 2013, 2009, 2005 by Saunders, an imprint of Elsevier Inc.
A Silent Evil Q Fever WAQAS RAFIQUE ALI DVM (RVMP) MPHIL NIBGE/ PIEAS (CONT.)
Measles.
Outbreak Investigations
Copyright © 2017 American Academy of Pediatrics.
Transmission Pathways: Airborne Disease
M. Benoit, Y. Bechah, C. Capo, P.J. Murray, J.L. Mege, B. Desnues 
Efficiency of a phase 1 vaccine for the reduction of vaginal Coxiella burnetii shedding in a clinically affected goat herd  E. Rousset, B. Durand, J.L.
H. Lepidi, F. Gouriet, D. Raoult  Clinical Microbiology and Infection 
Today’s EQ: How does our body fight off diseases and infections?
Sensitivity, specificity, positive predictive value, and negative predictive value for the different cutoffs used. Sensitivity, specificity, positive predictive.
R. Cantón  Clinical Microbiology and Infection 
Development and evaluation of a multiplex test for the detection of atypical bacterial DNA in community-acquired pneumonia during childhood  J.A. Carrillo,
Meropenem versus imipenem/cilastatin as empirical monotherapy for serious bacterial infections in the intensive care unit  C. Verwaest  Clinical Microbiology.
Hantavirus infections
Development and evaluation of a multiplex test for the detection of atypical bacterial DNA in community-acquired pneumonia during childhood  J.A. Carrillo,
Structural studies of lipid A from a lipopolysaccharide of the Coxiella burnetii isolate RSA 514 (Crazy)  P. Vadovic, A. Fuleova, R. Ihnatko, L. Skultety,
F. De Massis, A. Di Girolamo, A. Petrini, E. Pizzigallo, A. Giovannini 
Symposia and Oral Presentations
Immunohistochemical detection of Coxiella burnetii in an aortic graft
Clinical Microbiology and Infection
Presentation transcript:

Pathogenic Microbiology

Bacterial Laboratory Acquired Infections 76% of exposures occurred in clinical labs; 6% in vaccine manufacturing facilities; 8% in research labs. Exposure modes: 60% inhalation, other exposure modes included ingestion (intentional, poor technique such as mouth pipetting, smoking and eating in the lab) and secondary transmission.

Viral Laboratory Acquired Infections >70% associated with research labs; 32% of all viral LAIs associated with animals 18% of total were Hantavirus; of these, 8% were working with known infectious material or rodents - others thought they were working with uninfected rodents 16% were in clinical labs; rest were in production or field work Major exposure modes: inhalation, percutaneous (especially from animals)

Rickettsial Laboratory Acquired Infections All rickettsial LAIs were associated with research laboratories 95% of overt infections were by Coxiella burnetii; remainder were Murine typhus All Q fever cases by inhalation; all infected staff worked with or were in close proximity to sheep Remaining cases were by percutaneous, inhalation, mucous membrane or unknown exposure modes